vimarsana.com

Page 74 - தொழிற்சங்கம் ஆரோக்கியம் அமைச்சர் டாக்டர் கடுமையான வர்தன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patanjali Ayurved Acharya Balkrishna coronil IMA remarks Health Minister Dr Harsh Vardhan

URL copied Balkrishna defends Coronil, wants doctors association to withdraw remarks In his response to Indian Medical Association (IMA), Acharya Balkrishna, Patanjali’s managing director on Wednesday released a statement clarifying that Coronil has been awarded the CoPP licence as per WHO-GMP. He asserted that Union Health Minister Dr Harsh Vardhan didn t endorse any ayurvedic medicine and neither did he undermine modern medicines.  Earlier this week, IMA had expressed shock over the blatant lie of WHO certification for Patanjali s Coronil tablet, which the company claimed is an evidence-based medicine to fight COVID-19. The association also demanded an explanation from the union health minister in whose presence the medicine was launched.

Coronil no way a secret medicine, Patanjali issues fact check as response to IMA

The Patanjali Research Foundation Trust also said such statements are clearly an affront to the ancient practice of Ayurveda and the practitioners thereof.  Further such statements are contrary to the policy of the Government of India to facilitate the growth of nature-based medicines through its respective Ministries, as well as the regulatory bodies, the Patanjali Research Foundation Trust stated. The co-founder of Patanjali Yogpeeth Haridwar, Acharya Balkrishna, said that Coronil has been awarded the CoPP licence as per WHO-GMP.  Ayurveda has moved to the world stage, for COVID-19 pandemic. Opponents of Ayurveda are panicked, Acharya Balkrishna wrote. The Patanjali Research Foundation Trust s statement also read, In the press conference held on February 19, 2021, honourable Health Minister Dr Harsh Vardhan jee communicated about the integration of Ayurveda with the national healthcare system, which was in-line with recent initiatives of WHO, as stated by Dr Tedros Ghebr

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.